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system were reviewed. IORT-related effects and early 
postoperative outcome were assessed.  
Results: Seventy eight patients (median age 67 years) 
underwent lumpectomy, sentinel lymph node biopsy, and 
concurrent IORT from march 2013 to march 2014. Ninety-five 
percent of patients had invasive ductal histology with a 
median tumor size of 1.5 cm.  
Conclusions: While a variety of APBI techniques are currently 
available for clinical use, our early Latin American operative 
experience with IORT shows it is well tolerated with low 
morbidity. The addition of WBI may be necessary in situations 
for positive residual margins or microscopic nodal disease in 
patients who do not undergo additional surgery. 
Implementation of IB impacts treatment planning and 
operating room use in a multidisciplinary breast cancer 
program. The safety profile, ease of administration, and 
reduced costs of IB favor its more widespread use in selected 
patients with early-stage breast cancer. 
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Purpose/Objective: The Intrabeam system is a miniature 
accelerator emitting a 50 kV isotropic radiation. Its flat and 
surface applicators convert a spherical dose distribution into 
a flat one. This study aims at characterizing the dosimetric 
behaviour of these applicators for dermatologic applications. 
Materials and Methods: Dosimetric characterization was 
carried out in two steps. Firstly characterization was made in 
standard conditions for dermatologic applications, which is 
with the applicator directly on contact with the skin. 
Secondly, characterization was made in more clinical 
conditions, with obliquities and heterogeneities. 
Results: Behaviours of flat and surface applicators are 
different and have already been studied before. In standard 
conditions, dose rates and dose distribution results differ 
from previously published studies due to differences in the x-
ray source design. The study showed that when contact 
between the applicator and the skin of the patient is not 
perfect there is a dose distribution spread on the edge of the 
irradiation field where the contact is not made. Dose loss due 
to lack of backscatter radiations is significant. By contrast, 
influence of a denser material behind the measurement point 
has no significant influence on the dose at this point. 
Thickness of tissue treated with flat and surface applicators 
is only a few millimetres, depending on the applicator's size. 
Conclusions: The INTRABEAM® system with surface and flat 
applicators is a reliable way of treating superficial cutaneous 
malignancies as long as there is a good contact between the 
applicator and the skin.  
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Purpose/Objective: The main purpose of this study was to 
investigate the capability of EBT3 Gafchromic films to 
measure the delivered dose to the tumour bed and skin for 
intraoperative radiotherapy under clinical conditions in order 
to implement a protocol for in vivo dosimetry. 
Materials and Methods: This work has been performed using 
the 50 kV X-ray source from the Intrabeam® instrument (Carl 
Zeiss, Germany). EBT3 Gafchromic films were characterised 
within a water phantom and then used for in vivo dosimetry.  
Results: EBT3 Gafchromic films were found to be feasible for 
in vivo dosimetry. Measurements were performed in 10 
patients resulting in measured doses from 9.04 to 17.71 Gy in 
the tumour bed and from 0.87 to 3.98 Gy on the skin.  
Conclusions: EBT3 Gafchromic films offered an accurate 
method for the measurement of both the tumour bed and 
skin.  
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Purpose/Objective: Head and neck squamous cell carcinoma 
(HNSCC) is frequently characterized by overexpression of 
anti-apoptotic Bcl-2 family members. Increased levels of 
these anti-apoptotic proteins has been associated with radio- 
and chemoresistance and poor clinical outcome. Inhibition of 
anti-apoptotic Bcl-2 family members therefore represents an 
appealing strategy to overcome resistance to anticancer 
therapies. The aim of this study was to show enhanced 
radiation-induced tumor cell kill in HNSCC tumor cell lines in 
vitro, upon combined treatment with the pan-Bcl-2 inhibitor 
AT-101 and radiation. Additionally, we aimed to compare the 
effective in vitro concentrations with human serum levels of 
AT-101 obtained from a phase I/II trial, to substantiate 
therapeutic opportunities. 
